» Articles » PMID: 33679375

Mitochondrial Dysfunction and Oxidative Stress in Alzheimer's Disease

Overview
Specialty Geriatrics
Date 2021 Mar 8
PMID 33679375
Citations 176
Authors
Affiliations
Soon will be listed here.
Abstract

Mitochondria play a pivotal role in bioenergetics and respiratory functions, which are essential for the numerous biochemical processes underpinning cell viability. Mitochondrial morphology changes rapidly in response to external insults and changes in metabolic status via fission and fusion processes (so-called mitochondrial dynamics) that maintain mitochondrial quality and homeostasis. Damaged mitochondria are removed by a process known as mitophagy, which involves their degradation by a specific autophagosomal pathway. Over the last few years, remarkable efforts have been made to investigate the impact on the pathogenesis of Alzheimer's disease (AD) of various forms of mitochondrial dysfunction, such as excessive reactive oxygen species (ROS) production, mitochondrial Ca dyshomeostasis, loss of ATP, and defects in mitochondrial dynamics and transport, and mitophagy. Recent research suggests that restoration of mitochondrial function by physical exercise, an antioxidant diet, or therapeutic approaches can delay the onset and slow the progression of AD. In this review, we focus on recent progress that highlights the crucial role of alterations in mitochondrial function and oxidative stress in the pathogenesis of AD, emphasizing a framework of existing and potential therapeutic approaches.

Citing Articles

Promising Natural Remedies for Alzheimer's Disease Therapy.

Thawabteh A, Ghanem A, AbuMadi S, Thaher D, Jaghama W, Karaman D Molecules. 2025; 30(4).

PMID: 40005231 PMC: 11858286. DOI: 10.3390/molecules30040922.


Effect of N-Acetyl Cysteine as an Adjuvant Treatment in Alzheimer's Disease.

Lomeli Martinez S, Pacheco Moises F, Bitzer-Quintero O, Ramirez-Jirano J, Delgado-Lara D, Cortes Trujillo I Brain Sci. 2025; 15(2).

PMID: 40002497 PMC: 11852533. DOI: 10.3390/brainsci15020164.


Therapeutic Role of Heterocyclic Compounds in Neurodegenerative Diseases: Insights from Alzheimer's and Parkinson's Diseases.

Puranik N, Song M Neurol Int. 2025; 17(2).

PMID: 39997657 PMC: 11858632. DOI: 10.3390/neurolint17020026.


intronic expansion identified by poly-glycine-arginine pathology increases Alzheimer's disease risk.

Nguyen L, Ajredini R, Guo S, Romano L, Tomas R, Bell L Proc Natl Acad Sci U S A. 2025; 122(7):e2416885122.

PMID: 39937857 PMC: 11848317. DOI: 10.1073/pnas.2416885122.


The search for a blood-based biomarker for Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome (ME/CFS): from biochemistry to electrophysiology.

Clarke K, Kingdon C, Hughes M, Lacerda E, Lewis R, Kruchek E J Transl Med. 2025; 23(1):149.

PMID: 39905423 PMC: 11792299. DOI: 10.1186/s12967-025-06146-6.


References
1.
Kim S, Vlkolinsky R, Cairns N, Lubec G . Decreased levels of complex III core protein 1 and complex V beta chain in brains from patients with Alzheimer's disease and Down syndrome. Cell Mol Life Sci. 2000; 57(12):1810-6. PMC: 11146938. DOI: 10.1007/pl00000661. View

2.
Ryu D, Mouchiroud L, Andreux P, Katsyuba E, Moullan N, Nicolet-Dit-Felix A . Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents. Nat Med. 2016; 22(8):879-88. DOI: 10.1038/nm.4132. View

3.
Butterfield D, Reed T, Sultana R . Roles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer's disease. Free Radic Res. 2010; 45(1):59-72. DOI: 10.3109/10715762.2010.520014. View

4.
Pena-Blanco A, Haschka M, Jenner A, Zuleger T, Proikas-Cezanne T, Villunger A . Drp1 modulates mitochondrial stress responses to mitotic arrest. Cell Death Differ. 2020; 27(9):2620-2634. PMC: 7429963. DOI: 10.1038/s41418-020-0527-y. View

5.
Frezza C, Cipolat S, Martins de Brito O, Micaroni M, Beznoussenko G, Rudka T . OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell. 2006; 126(1):177-89. DOI: 10.1016/j.cell.2006.06.025. View